Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade

Next Previous
Trial Profile

Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Aliskiren (Primary) ; Metoprolol
  • Indications Essential hypertension
  • Focus Pharmacodynamics

Most Recent Events

  • 12 Jul 2011 Planned end date changed from 1 Mar 2012 to 1 May 2010 as reported by ClinicalTrials.gov.
  • 04 Jun 2010 Status changed from recruiting to discontinued.
  • 02 Jun 2010 Actual patient number (1) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top